Funding for this research was provided by:
Netherlands Heart Institute (CVON2019-2 OUTREACH)
Article History
Received: 14 July 2025
Accepted: 12 November 2025
First Online: 11 March 2026
Declarations
:
: Jeroen Bakkers is co-inventor on a patent application: patent No. PCT/NL2022/050553 “Mammalian heart regeneration”. Jeroen Bakkers is co-founder of Myogene Therapeutics. The remaining authors declare no conflicts of interest.